Literature DB >> 23242281

Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration.

Cornelia Laule1, Vlady Pavlova, Esther Leung, Guojun Zhao, Alex L MacKay, Piotr Kozlowski, Anthony L Traboulsee, David K B Li, G R Wayne Moore.   

Abstract

Although multiple sclerosis (MS) lesions have been studied extensively using histology and magnetic resonance imaging (MRI), little is known about diffusely abnormal white matter (DAWM). Diffusely abnormal white matter, regions with reduced mild MRI hyperintensity and ill-defined boundaries, show reduced myelin water fraction, and decreased Luxol fast blue staining of myelin phospholipids, with relative preservation of myelin basic protein and 2',3'-cyclic-nucleotide 3'-phosphohydrolase. Because DAWM may be important in MS disability and progression, further histologic characterization is warranted. The MRI data were collected on 14 formalin-fixed MS brain samples that were then stained for myelin phospholipids, myelin proteins, astrocytes and axons. Diffusely abnormal white matter showed reduced myelin water fraction (-30%, p < 0.05 for 13 samples). Myelin phospholipids showed the most dramatic and consistent histologic reductions in staining optical density (-29% Luxol fast blue and -24% Weil's, p < 0.05 for 13 and 14 samples,respectively) with lesser myelin protein involvement (-11% myelin-associated glycoprotein, -10% myelin basic protein, -8% myelin-oligodendrocyte glycoprotein, -7% proteolipid protein, -5% 2',3'-cyclic-nucleotide 3'-phosphohydrolase, p < 0.05 for 3, 3, 1, 2, and 3 samples, respectively). Axonal involvement was intermediate. Diffusely abnormal white matter lipid and protein reductions occurred independently. These findings suggest a primary lipid abnormality in DAWM that exceeds protein loss and is accompanied by axonal degeneration. These phenomena may be important in MS pathogenesis and disease progression, which is prominent in individuals with DAWM.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23242281     DOI: 10.1097/NEN.0b013e31827bced3

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  16 in total

1.  Nile Red fluorescence spectroscopy reports early physicochemical changes in myelin with high sensitivity.

Authors:  Wulin Teo; Andrew V Caprariello; Megan L Morgan; Antonio Luchicchi; Geert J Schenk; Jeffrey T Joseph; Jeroen J G Geurts; Peter K Stys
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-23       Impact factor: 11.205

2.  The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.

Authors:  N K Singhal; H Huang; S Li; R Clements; J Gadd; A Daniels; E E Kooijman; P Bannerman; T Burns; F Guo; D Pleasure; E Freeman; L Shriver; J McDonough
Journal:  Exp Brain Res       Date:  2016-10-05       Impact factor: 1.972

3.  Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis.

Authors:  T Gabelic; D P Ramasamy; B Weinstock-Guttman; J Hagemeier; C Kennedy; R Melia; D Hojnacki; M Ramanathan; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-25       Impact factor: 3.825

Review 4.  From the prodromal stage of multiple sclerosis to disease prevention.

Authors:  Ruth Ann Marrie; Mark Allegretta; Lisa F Barcellos; Bruce Bebo; Peter A Calabresi; Jorge Correale; Benjamin Davis; Philip L De Jager; Christiane Gasperi; Carla Greenbaum; Anne Helme; Bernhard Hemmer; Pamela Kanellis; Walter Kostich; Douglas Landsman; Christine Lebrun-Frenay; Naila Makhani; Kassandra L Munger; Darin T Okuda; Daniel Ontaneda; Ronald B Postuma; Jacqueline A Quandt; Sharon Roman; Shiv Saidha; Maria Pia Sormani; Jon Strum; Pamela Valentine; Clare Walton; Kathleen M Zackowski; Yinshan Zhao; Helen Tremlett
Journal:  Nat Rev Neurol       Date:  2022-07-15       Impact factor: 44.711

5.  Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα-mediated lipid metabolism.

Authors:  Xin Zhou; Chenxi He; Jiangong Ren; Congxin Dai; Sharon R Stevens; Qianghu Wang; Daniel Zamler; Takashi Shingu; Liang Yuan; Chythra R Chandregowda; Yunfei Wang; Visweswaran Ravikumar; Arvind Uk Rao; Feng Zhou; Hongwu Zheng; Matthew N Rasband; Yiwen Chen; Fei Lan; Amy B Heimberger; Benjamin M Segal; Jian Hu
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 6.  Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

Authors:  Ruth Geraldes; Margaret M Esiri; Gabriele C DeLuca; Jacqueline Palace
Journal:  Brain Pathol       Date:  2017-03-12       Impact factor: 6.508

7.  Untangling the R2* contrast in multiple sclerosis: A combined MRI-histology study at 7.0 Tesla.

Authors:  Francesca Bagnato; Simon Hametner; Emma Boyd; Verena Endmayr; Yaping Shi; Vasiliki Ikonomidou; Guanhua Chen; Siddharama Pawate; Hans Lassmann; Seth Smith; E Brian Welch
Journal:  PLoS One       Date:  2018-03-21       Impact factor: 3.240

8.  New rapid, accurate T2 quantification detects pathology in normal-appearing brain regions of relapsing-remitting MS patients.

Authors:  Timothy M Shepherd; Ivan I Kirov; Erik Charlson; Mary Bruno; James Babb; Daniel K Sodickson; Noam Ben-Eliezer
Journal:  Neuroimage Clin       Date:  2017-02-03       Impact factor: 4.881

9.  Gray Matter Atrophy Is Primarily Related to Demyelination of Lesions in Multiple Sclerosis: A Diffusion Tensor Imaging MRI Study.

Authors:  Eszter Tóth; Nikoletta Szabó; Gergõ Csete; András Király; Péter Faragó; Tamás Spisák; Krisztina Bencsik; László Vécsei; Zsigmond T Kincses
Journal:  Front Neuroanat       Date:  2017-03-29       Impact factor: 3.856

Review 10.  Advances in Intravital Non-Linear Optical Imaging of the Central Nervous System in Rodents.

Authors:  Geneviève Rougon; Sophie Brasselet; Franck Debarbieux
Journal:  Brain Plast       Date:  2016-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.